2000 SIERRA POINT PARKWAY, BRISBANE, CA
Reports Second Quarter 2025 Financial Results and Provides Business Update
News, Securities Holder Rights or Indentures, Legal Opinion, Material Contracts
Other Events
Changes in Board, Management or Compensation
Reports First Quarter 2025 Financial Results and Provides Business Update
Costs of Shutting Down or Selling Parts of the Business
Announces Plan to Explore Strategic Alternatives to Advance Promising Pipeline of Clinical Oncology Assets and Maximize Stockholder Value
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Amended Registration of Securities
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13D - Ownership Report
S-8 POS
Correspondence